NOW ENROLLING
More information >

PRESENTATIONS
Activity of Tesetaxel, an Oral Taxane, Given as a Single-agent in Patients with HER2-, Hormone Receptor + (HR+) Metastatic Breast Cancer (MBC) in a Phase 2 Study – Presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting